APA

Jansson K. H., Tucker J. B., Stahl L. E., Simmons J. K., Fuller C., Beshiri M. L., Agarwal S., Fang L., Hynes P. G., Alilin A. N., Lake R., Abbey Y. C., Cawley J., Tice C. M., Yin J., McKnight C., Klummp-Thomas C., Zhang X., Guha R., Hoover S., Simpson R. M., Nguyen H. M., Corey E., Thomas C. J., Proia D. A. & Kelly K. (20191024). High-throughput screens identify HSP90 inhibitors as potent therapeutics that target inter-related growth and survival pathways in advanced prostate cancer. : Scientific reports.

Chicago

Jansson Keith H, Tucker John B, Stahl Lauren E, Simmons John K, Fuller Caitlyn, Beshiri Michael L, Agarwal Supreet, Fang Lei, Hynes Paul G, Alilin Aian Neil, Lake Ross, Abbey Yasmine C, Cawley Jacob, Tice Caitlin M, Yin JuanJuan, McKnight Crystal, Klummp-Thomas Carleen, Zhang Xiaohu, Guha Rajarshi, Hoover Shelley, Simpson R Mark, Nguyen Holly M, Corey Eva, Thomas Craig J, Proia David A and Kelly Kathleen. 20191024. High-throughput screens identify HSP90 inhibitors as potent therapeutics that target inter-related growth and survival pathways in advanced prostate cancer. : Scientific reports.

Harvard

Jansson K. H., Tucker J. B., Stahl L. E., Simmons J. K., Fuller C., Beshiri M. L., Agarwal S., Fang L., Hynes P. G., Alilin A. N., Lake R., Abbey Y. C., Cawley J., Tice C. M., Yin J., McKnight C., Klummp-Thomas C., Zhang X., Guha R., Hoover S., Simpson R. M., Nguyen H. M., Corey E., Thomas C. J., Proia D. A. and Kelly K. (20191024). High-throughput screens identify HSP90 inhibitors as potent therapeutics that target inter-related growth and survival pathways in advanced prostate cancer. : Scientific reports.

MLA

Jansson Keith H, Tucker John B, Stahl Lauren E, Simmons John K, Fuller Caitlyn, Beshiri Michael L, Agarwal Supreet, Fang Lei, Hynes Paul G, Alilin Aian Neil, Lake Ross, Abbey Yasmine C, Cawley Jacob, Tice Caitlin M, Yin JuanJuan, McKnight Crystal, Klummp-Thomas Carleen, Zhang Xiaohu, Guha Rajarshi, Hoover Shelley, Simpson R Mark, Nguyen Holly M, Corey Eva, Thomas Craig J, Proia David A and Kelly Kathleen. High-throughput screens identify HSP90 inhibitors as potent therapeutics that target inter-related growth and survival pathways in advanced prostate cancer. : Scientific reports. 20191024.